Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Irfan A Asangani, Paul W Harms, Lois Dodson, Mithil Pandhi, Lakshmi P Kunju, Christopher A Maher, Douglas R Fullen, Timothy M Johnson, Thomas J Giordano, Nallasivam Palanisamy, Arul M Chinnaiyan
Published Aug 31, 2012 · Vol. 3, No. 9 · pp. 1011-1025
Julia Feichtinger, Ibrahim Aldeailej, Rebecca Anderson, Mikhlid Almatrafi, Naif Alsiwiehri, keith Griffiths, Nicholas Stuart, Jane A Wakeman, Lee Larcombe, Ramsay James McFarlane
Published Aug 13, 2012 · Vol. 3, No. 8 · pp. 843-853
Keywords: cancer biomarkers, cancer testes antigens, oncogenes, meiosis, PRDM9, cohesins drug targets
J Scott Nystrom, John C. Hornberger, Gauri R. Varadhachary, Richard J. Hornberger, Hialy R. Gutierrez, W. David Henner, Shawn H. Becker, Mahul B. Amin, Michael G. Walker
Published Jun 9, 2012 · Vol. 3, No. 6 · pp. 620-628
Keywords: cancer of unknown primary, diagnosis, genomics, clinical utility, tissue of origin
Veronique Mathieu, Christine Pirker, Wolfgang M Schmidt, Sabine Spiegl-Kreinecker, Daniela Lötsch, Petra Heffeter, Balazs Hegedus, Michael Grusch, Robert Kiss, Walter Berger
Published Apr 24, 2012 · Vol. 3, No. 4 · pp. 399-413